Hostname: page-component-6766d58669-h8lrw Total loading time: 0 Render date: 2026-05-15T10:14:02.971Z Has data issue: false hasContentIssue false

Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial – CORRIGENDUM

Published online by Cambridge University Press:  13 May 2026

Rights & Permissions [Opens in a new window]

Abstract

Information

Type
Corrigendum
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2026. Published by Cambridge University Press on behalf of Royal College of Psychiatrists
Supplementary material: File

Beidas et al. supplementary material

Beidas et al. supplementary material
Download Beidas et al. supplementary material(File)
File 70.4 KB
Submit a response

eLetters

No eLetters have been published for this article.